BioSpace News Archive

Ault Life Sciences™, Inc. (“ALSI” or the “Company”), a Delaware corporation, invites everyone interested in Alzheimer’s disease to watch an eye-opening interview on the #KOalz podcast show with Dr. Thomas Wisniewski, the Clinical Director of the Pearl I. Barlow Center for Memory Evaluation and Treatment, use this link.

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced the publication of data from two new analyses of patients treated with ZILRETTA (triamcinolone acetonide injectable suspension), including an analysis of 305 patients in the Phase 3 and Phase 3b trials that showed treatment with ZILRETTA resulted in no deleterious impact on joint structure.

Trax Management Services Inc. announced today the introduction of the PhoenixDx 2019-nCoV to North America, a COVID-19 test kit that recently received an Emergency Use Authorization from the FDA.

The American Society for Preventive Cardiology has released an official scientific statement titled: Continuity of Care and Outpatient Management for Patients With and At High Risk for Cardiovascular Disease During the COVID-19 Pandemic: A Scientific Statement.

Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company” or “Pulse Biosciences”), a novel bioelectric medicine company, today announced that it has updated the structure, key dates and pricing terms for its previously-announced rights offering.

XBiotech Inc. (NASDAQ: XBIT) announced today that human immune donors have now been identified that can support the Company’s development of a True Human™ antibody therapy for COVID-19

Convalescent plasma (i.e., the component of blood known as plasma obtained from people who have recovered from COVID-19)

The American Journal of Managed Care® (AJMC®), the leading peer-reviewed journal dedicated to issues in managed care, is pleased to announce that nominations are being accepted for the 2020 Seema S. Sonnad Emerging Leader in Managed Care Research Award through July 15, 2020.

Bravado Health today announced a partnership with K-Rain to screen employees daily for symptoms of coronavirus disease (COVID-19).

GeoVax Labs, Inc., a biotechnology company developing human vaccines and immunotherapies against infectious diseases and cancer, announced today that Beijing- and Philadelphia-based Sino Biological, Inc. will be its exclusive supplier of SARS-CoV-2 (COVID-19) bioreagent research products.